Pharma channel feed

Gilead re­ports 'flat' Q3 rev­enues, cuts PhI­II Covid tri­al

Last year
R&D

Bay­er un­veils big changes to busi­ness and head­count to ad­dress ‘not ac­cept­able’ per­for­mance

Last year
R&D

Ac­tivist in­vestor El­liott buys $1B+ stake in Bio­Marin as CEO change nears

Last year

Ei­sai eyes long game for Leqem­bi amid ‘dra­mat­i­cal­ly’ in­creas­ing pa­tient use

Last year

Sen­ate con­firms Mon­i­ca Bertag­nol­li to lead NIH with bi­par­ti­san 62-36 vote

Last year
FDA+

French au­thor­i­ties in­ves­ti­gate Sanofi over mar­ket ma­nip­u­la­tion, mis­lead­ing fi­nan­cial com­mu­ni­ca­tions

Last year
Law

Mar­ket­ingRx roundup: Sanofi, Re­gen­eron re­new Dupix­ent asth­ma ef­fort; Bausch Health bat­tles sea­son­al af­fec­tive dis­or­der

Last year
Marketing

Pfiz­er gath­ers Covid cam­paign 'i­con­s' Martha Stew­art, John Leg­end, Travis Kelce and more for lat­est boost­er push

Last year
Marketing

Lil­ly backs Or­so­Bio's $60M Se­ries A for PhII tri­als in obe­si­ty and NASH

Last year
Financing
Startups

Ver­tex dis­con­tin­ues a PhII rare dis­ease drug, sets ear­ly 2024 time­line for piv­otal non-opi­oid pain pill read­out

Last year
R&D

'Pull every lev­er': Marks dou­bles down on ur­gency to im­prove gene ther­a­py man­u­fac­tur­ing

Last year
Cell/Gene Tx
FDA+

Bris­tol My­er­s' new ef­fort spot­lights pso­ri­a­sis pa­tients and physi­cians from around the world

Last year
Marketing

Court may ex­pand 340B drug dis­count pro­gram as CMS preps $9B for 1,700 hos­pi­tals

Last year
Law

HHS says Ste­lara may be de­s­e­lect­ed from Medicare ne­go­ti­a­tions, de­pend­ing on biosim­i­lar launch

Last year
FDA+

Bris­tol My­ers buys Orum Ther­a­peu­tic­s' pro­tein de­grad­er take on AD­Cs for $100M up­front

Last year
Startups
Deals

BIO, PhRMA press FDA for con­crete de­tails on new IT strat­e­gy

Last year
FDA+

What's fair: ICER re­port finds in­sur­er cov­er­age typ­i­cal­ly meets ac­cess cri­te­ria for 18 pre­scrip­tion drugs

Last year

Pfiz­er to cut 200 jobs at Michi­gan plant that makes Covid prod­ucts

Last year
People
R&D

As weight loss lead­ers boom, one biotech con­tender aban­dons its quest with Chap­ter 7 liq­ui­da­tion

Last year

Phath­om notch­es FDA ap­proval for Vo­quez­na to treat ero­sive GERD

Last year
FDA+

Ot­su­ka part­ners with for­mer Olympic swim­mer on kid­ney dis­ease cam­paign

Last year
Marketing

US ar­gues that As­traZeneca's IRA suit 'fares no bet­ter than the oth­er­s'

Last year
Law

House Re­pub­li­cans threat­en FDA with sub­poe­na over al­leged in­ad­e­quate lab safe­ty over­sight

Last year
FDA+

FDA par­tial­ly halts Nurix Ther­a­peu­tics’ can­cer tri­al as it im­proves man­u­fac­tur­ing process

Last year
FDA+
Manufacturing
First page Previous page 91929394959697 Next page Last page
A service from the Financial Times